Do you add ADT to RT for a patient with intermediate-risk prostate cancer with discordant Decipher and ArteraAI results?

For example, if a patient with intermediate risk prostate cancer has a high risk Decipher score (10 year risk of metastasis with standard therapy of >15%), but is low risk by ArteraAI and is biomarker negative, would you add ADT to RT?

Answer from: Radiation Oncologist at Community Practice

This will be a long response to try to provide transparency to these tests from what I know as a researcher and clinician. I also clinically see this situation frequently. We have made incredible progress in developing biomarkers in prostate cancer, but it is important to know that no single test is...

Comments

Radiation Oncologist at Community Health Network
Thanks for the thorough explanation

Radiation Oncologist at Beth Israel Deaconess Medical Center/Harvard Medical School
Please disclose possible conflict of interests

Radiation Oncologist at Case Western Reserve University/ University Hospitals Seidman Cancer Center
None with any companies discussed. Hence, why none...

Radiation Oncologist at UMass Memorial Medical Group
Exceptionally well-written and insightful answer, ...

Radiation Oncologist at Kansas City VA Medical Center
This is a great response and mini-course on Deciph...

Radiation Oncologist at Precision Radiation Oncology
What is the utility for any of the other biomarker...

Radiation Oncologist at Jacob E Locke MD PA
Nice summary.. thanks!

Radiation Oncologist at Rush Medical College of Rush University
Very nice, well-written response! The risks for DM...

Please select the option that best describes you:

Do you add ADT to RT for a patient with intermediate-risk prostate cancer with discordant Decipher and ArteraAI results?

Related Questions